Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Card: All Sponsors Return For 2005 Run-Up To Part D Benefit

This article was originally published in The Pink Sheet Daily

Executive Summary

Re-enrollment period for 2005 Medicare drug discount card program offers all 34 national cards currently available. Sponsors' continued interest speaks to the program's importance as a "loss leader" to participating in the Part D drug benefit market in 2006.

You may also be interested in...



Medicare Rx Plan Numbers Will Not Match Card Sponsor Totals, CMS’ McClellan Predicts

Seniors will not be overwhelmed by a high number of plan choices, the agency administrator maintains. CMS has received a large volume of Part D applications, but not all look “complete and serious,” McClellan indicates.

Medicare Rx Plan Numbers Will Not Match Card Sponsor Totals, CMS’ McClellan Predicts

Seniors will not be overwhelmed by a high number of plan choices, the agency administrator maintains. CMS has received a large volume of Part D applications, but not all look “complete and serious,” McClellan indicates.

Discount Card Enrollment Runs “Way Ahead” Of Similar Programs – McClellan

Enrollment in the Medicare drug discount card is outpacing all other previous voluntary programs at HHS, Centers for Medicare & Medicaid Services Administrator McClellan said

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS058428

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel